Oleoylethanolamide enhances β-adrenergic-mediated thermogenesis and white-to-brown adipocyte phenotype in epididymal white adipose tissue in rat
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Summary: β-adrenergic receptor activation promotes brown adipose tissue (BAT) β-oxidation and thermogenesis by burning fatty acids during uncoupling respiration. Oleoylethanolamide (OEA) can inhibit feeding and stimulate lipolysis by activating the peroxisome proliferator-activating receptor-α (PPARα) in the white adipose tissue (WAT). Here we explore whether PPARα activation potentiates the effect of β3-adrenergic stimulation on energy balance mediated by the respective agonists OEA and CL316243. The effect of this pharmacological association was monitored on feeding, thermogenesis, β-oxidation and lipid/cholesterol metabolism in epididymal (e)WAT. CL316243 (1 mg/kg) and OEA (5 mg/kg) co-administration over 6 days enhanced the reduction of food intake and body weight gain, increased the energy expenditure and reduced the respiratory quotient (VCO2/VO2). This negative energy balance agreed with decreased fat mass and increased BAT weight and temperature, as well as lowered plasma levels of triglycerides, cholesterol, NEFAs and the adipokines leptin and TNF-α. Regarding eWAT, CL316243 and OEA treatment elevated the thermogenic factors PPARα and UCP1, reduced p38-MAPK phosphorylation, and promoted brown-like features in the white adipocytes, as the mitochondrial (Cox4i1, Cox4i2) and BAT (Fgf21, Prdm16) genes were over-expressed in eWAT. The enhancement of the fatty acid β-oxidation factors Cpt1b and Acox1 in eWAT was accompanied with an up-regulation of de novo lipogenesis and a reduction of the unsaturated fatty acid synthesis enzyme Scd1. We propose that the combination of β-adrenergic and PPARα receptor agonists promote therapeutic adipocyte remodelling in eWAT that confer a potential clinical utility for the treatment of obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional Brown Adipose Tissue in Healthy Adults
Virtanen, K. A., Lidell, M. E., Orava, J., Heglind, M., Westergren, R., Niemi, T., Taittonen, M., Laine, J., Savisto, N.-J., Enerbäck, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808949 · Cited by 3,058 · cited 2×
“Given that BAT has traditionally been considered to show discrete physiological relevance in humans (Cannon and Nedergaard, 2004; Virtanen et al., 2009), it is reasonable to anticipate that the effect of β3-adrenergic agonists on energy expenditure in humans will be less efficient than might be…”
BackgroundPRDM16 controls a brown fat/skeletal muscle switch
Seale, P., Bjork, B., Yang, W., Kajimura, S., Chin, S., Kuang, S., Scimè, A., Devarakonda, S., Conroe, H. M., Erdjument-Bromage, H., et al. (2008) · Nature · doi:10.1038/nature07182 · Cited by 2,347 · cited 2×
“…16 (PRDM16), fibroblast growth factor (FGF)-21, PPARγ coactivator 1α (PGC-1α) and prostaglandins, have been proposed to induce a BAT-specific gene expression profile in response to adrenergic stimulation (Seale et al., 2007; Seale et al., 2008; Seale et al., 2011; Vegiopoulos et al., 2010).”
BackgroundFGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
Towards a molecular understanding of adaptive thermogenesis
Lowell, B. B., & Spiegelman, B. M. (2000) · Nature · doi:10.1038/35007527 · Cited by 1,630 · cited 4×
“, 2002), whereas β3adrenergic agonists elicit potent effects on energy homeostasis by suppressing food intake, and promoting body fat loss, lipid oxidation, oxygen consumption and mitochondrial biogenesis, as well as improving insulin sensitivity and glucose tolerance (Arch and Wilson, 1996; Granneman et al., 2005; Lo…”
BackgroundInfluentialBadman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., & Maratos-Flier, E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.002 · Cited by 1,495 · cited 1×
“…by the β3-adrenergic receptor agonist CL316243 (Li et al., 2005) and is a critical regulator of thermogenic key components, including PRDM16, FGF21, PGC-1α and UCP1, in BAT (Badman et al., 2007; Chartoumpekis et al., 2011; Hondares et al., 2011a; Hondares et al., 2011b; Villarroya et al., 2007).”
BackgroundFeldmann, H. M., Golozoubova, V., Cannon, B., & Nedergaard, J. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2008.12.014 · Cited by 1,318 · cited 1×
“The involvement of UCP1 in adrenergically induced thermogenesis demonstrates that UCP1 plays a significant role in the control of energy expenditure; its dysfunction contributes to the development and maintenance of obesity (Feldmann et al., 2009; Inokuma et al., 2006; Ricquier and Bouillaud, 2000).”
BackgroundRelationship between Adipocyte Size and Adipokine Expression and Secretion
Skurk, T., Alberti-Huber, C., Herder, C., & Hauner, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1055 · Cited by 1,288 · cited 2×
“Previous studies reported that leptin secretion is positively correlated with adiposity (Skurk et al., 2007), and that TNF-α action is implicated in inflammatory response and insulin resistance, at least in obesity (Zhang et al., 2002).”
BackgroundPetrovic, N., Walden, T. B., Shabalina, I. G., Timmons, J. A., Cannon, B., & Nedergaard, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.053942 · Cited by 1,263 · cited 1×
“…contrast, cold exposure or pharmacological activation of β3adrenergic receptors induces the appearance of brown fat-like (‘brite’) adipocytes in WAT (Cousin et al., 1992; Ishibashi and Seale, 2010; Petrovic et al., 2010), suggesting a mechanism for adipocyte progenitors to promote WAT remodelling.”
BackgroundTranscriptional Control of Brown Fat Determination by PRDM16
Seale, P., Kajimura, S., Yang, W., Chin, S., Rohas, L. M., Uldry, M., Tavernier, G., Langin, D., & Spiegelman, B. M. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.06.001 · Cited by 1,174 · cited 5×
“…16 (PRDM16), fibroblast growth factor (FGF)-21, PPARγ coactivator 1α (PGC-1α) and prostaglandins, have been proposed to induce a BAT-specific gene expression profile in response to adrenergic stimulation (Seale et al., 2007; Seale et al., 2008; Seale et al., 2011; Vegiopoulos et al., 2010).”
BackgroundInfluentialFibroblast Growth Factor 21 Corrects Obesity in Mice
Coskun, T., Bina, H. A., Schneider, M. A., Dunbar, J. D., Hu, C. C., Chen, Y., Moller, D. E., & Kharitonenkov, A. (2008) · Endocrinology · doi:10.1210/en.2008-0816 · Cited by 1,031
Thermogenic Activation Induces FGF21 Expression and Release in Brown Adipose Tissue
Hondares, E., Iglesias, R., Giralt, A., Gonzalez, F. J., Giralt, M., Mampel, T., & Villarroya, F. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.215889 · Cited by 623 · cited 6×
“…via a p38 MAPK mechanism in BAT, induces higher energy expenditure and body temperature, and triggers a lowering of glucose and triglyceride levels, improved insulin sensitization and enrichment of brown adipocytes (Coskun et al., 2008; Hondares et al., 2011a; Kharitonenkov et al., 2005).”
BackgroundInfluentialMultilocular fat cells in WAT of CL-316243-treated rats derive directly from white adipocytes
Himms-Hagen, J., Melnyk, A., Zingaretti, M. C., Ceresi, E., Barbatelli, G., & Cinti, S. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.279.3.c670 · Cited by 593 · cited 5×
“Specifically, β3-adrenergic activation stimulates the expression of uncoupling protein-1 (UCP1), a mitochondrial molecule involved in cold-induced nonshivering thermogenesis as well as dietinduced thermogenesis, by uncoupling the respiratory chain in specific adipocytes in both brown (BAT) and white (WAT) adipose tiss…”
BackgroundInfluentialAcquirement of brown fat cell features by human white adipocytes
Tiraby, C., Tavernier, G., Lefort, C., Larrouy, D., Bouillaud, F., Ricquier, D., & Langin, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305235200 · Cited by 474 · cited 1×
“However, several data point to a higher physiological relevance of β3-adrenergic stimulation when human white adipocytes acquire functional features (UCP1) of brown fat-like phenotypes (Cinti, 2009; Oberkofler et al., 1997; Tiraby et al., 2003).”
BackgroundGuzmán, M., Lo Verme, J., Fu, J., Oveisi, F., Blázquez, C., & Piomelli, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404087200 · Cited by 328 · cited 1×
“Interestingly, this metabolic response was potentiated by the lipolytic effect of OEA (Guzmán et al., 2004; Rodríguez de Fonseca et al., 2001), whereby this elevated capacity for β-oxidation within WAT contributes to insulin-sensitizing effects (lowering insulin resistance) and reduced…”
BackgroundGranneman, J. G., Li, P., Zhu, Z., & Lu, Y. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00009.2005 · Cited by 298 · cited 2×
“…homeostasis by suppressing food intake, and promoting body fat loss, lipid oxidation, oxygen consumption and mitochondrial biogenesis, as well as improving insulin sensitivity and glucose tolerance (Arch and Wilson, 1996; Granneman et al., 2005; Lowell and Spiegelman, 2000; White et al., 2004).”
BackgroundBrown Adipose Tissue Responds to Cold and Adrenergic Stimulation by Induction of FGF21
Chartoumpekis, D. V., Habeos, I. G., Ziros, P. G., Psyrogiannis, A. I., Kyriazopoulou, V. E., & Papavassiliou, A. G. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00075 · Cited by 252 · cited 4×
“…coactivators such as PGC-1α, highly expressed in BAT (Barbera et al., 2001), or the stimulus driven by cold acclimatization, high-fat feeding or higher free-fatty-acid mobilization from triglyceride stores, could be necessary in this process (Chartoumpekis et al., 2011; Seale et al., 2011).”
BackgroundInfluentialMurano, I., Barbatelli, G., Giordano, A., & Cinti, S. (2009) · Journal of Anatomy · doi:10.1111/j.1469-7580.2008.01001.x · Cited by 208
Cited by
Endocannabinoids–at the crossroads between the gut microbiota and host metabolism
Cani, P. D., Plovier, H., Van Hul, M., Geurts, L., Delzenne, N. M., Druart, C., & Everard, A. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.211 · Cited by 367
Lipid signaling in adipose tissue: Connecting inflammation & metabolism
Masoodi, M., Kuda, O., Rossmeisl, M., Flachs, P., & Kopecky, J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.09.023 · Cited by 221
Decara, J., Arrabal, S., Beiroa, D., Rivera, P., Vargas, A., Serrano, A., Pavón, F. J., Ballesteros, J., Dieguez, C., Nogueiras, R., et al. (2016) · BioFactors · doi:10.1002/biof.1295 · Cited by 42
Self-citationPazos, P., Lima, L., Tovar, S., González-Touceda, D., Diéguez, C., & García, M. C. (2015) · Scientific Reports · doi:10.1038/srep17977 · Cited by 33
Self-citation
Metadata
- Authors
- Suárez, J., Rivera, P., Arrabal, S., Crespillo, A., Serrano, A., Baixeras, E., Pavón, F. J., Cifuentes, M., Nogueiras, R., Ballesteros, J., Dieguez, C., & Rodríguez de Fonseca, F.
- Venue
- Disease Models & Mechanisms
- Publisher
- The Company of Biologists
- Published
- 2013-01-01
- Volume
- 7
- Issue
- 1
- Pages
- 129-41
- ISSN
- 1754-8403 (ISSN-L)
- 1754-8411
- OpenAlex
- W2146119241
- Cited by
- 60
- References
- 17
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.